PATENT CLAIM ANALYSIS

Application Number: 16121481
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["435", "005000"]

Abstract:
The invention provides diagnostic tests to distinguish between different pre-symptomatic neurodegenerative diseases.

Claim (Index 1):
A method of determining a quantity of a target oligomer in a biological fluid sample from a patient to determine an increased likelihood of having or developing a neurodegenerative disease, comprising;\n (a) contacting the sample to a solid support, wherein the solid support is coated with a capture agent specific for the target oligomer and is blocked with a blocking agent to form a bound sample; (b) incubating the bound sample; (c) contacting the bound sample with labelled phage specific for the target oligomer to form a labeled bound sample; (d) contacting the labeled bound sample with labeled detection agent to form a visualizable sample; and (e) comparing the quantity of the visualizable sample and to a control to determine the quantity of the target oligomer.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15424444', '15479110', '14434742', '15114356', '13821172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6281119094341504
- 35 USC 102 Novelty (BERT): 0.560341104160092
- Combined Prediction Score: 0.6213348289067446
- Mean Citation Score: 401.09184
- Max Citation Score: 474.53005999999993
- Similarity Product: 350.0737725448965

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test